Phase IIIb Clinical Trial of Quadrivalent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) for Age/Immunization Schedule Bridging
National Vaccine and Serum Institute, China
National Vaccine and Serum Institute, China
Hyperfine
ModernaTX, Inc.
GlaxoSmithKline
AION Biosystems
Avita Medical
Shandong Branden Med.Device Co.,Ltd
AlloVir
GlaxoSmithKline
Cellerant Therapeutics
Enzon Pharmaceuticals, Inc.
Sanofi
Eli Lilly and Company